Report cover image

Specialty Drug Distribution Market by Disease Indication (AIDS, Hemophilia, Multiple Sclerosis), Distributor Type (Full line Wholesalers, Specialty Distributors), Distribution Type, End-User - Global Forecast 2023-2030

Publisher 360iResearch
Published Oct 05, 2023
Length 190 Pages
SKU # IRE18312938

Description

Specialty Drug Distribution Market by Disease Indication (AIDS, Hemophilia, Multiple Sclerosis), Distributor Type (Full line Wholesalers, Specialty Distributors), Distribution Type, End-User - Global Forecast 2023-2030


The Specialty Drug Distribution Market is projected to reach USD 11.40 billion by 2030 from USD 3.83 billion in 2022, at a CAGR of 14.60% during the forecast period.

Market Segmentation & Coverage:

This research report analyzes various sub-markets, forecasts revenues, and examines emerging trends in each category to provide a comprehensive outlook on the Specialty Drug Distribution Market.
  • Based on Disease Indication, market is studied across AIDS, Hemophilia, Multiple Sclerosis, Oncology, and Rheumatoid Arthritis. The Oncology commanded largest market share of 24.76% in 2022, followed by Rheumatoid Arthritis.
  • Based on Distributor Type, market is studied across Full line Wholesalers and Specialty Distributors. The Full line Wholesalers commanded largest market share of 55.46% in 2022, followed by Specialty Distributors.
  • Based on Distribution Type, market is studied across Hospitals & Clinic Pharmacies, Independent Pharmacies, Large Chain Pharmacies, Mail-Order Pharmacies, Online Stores, and Specialty Pharmacies. The Hospitals & Clinic Pharmacies commanded largest market share of 36.31% in 2022, followed by Large Chain Pharmacies.
  • Based on End-User, market is studied across Ambulatory Surgical Centers, Healthcare Payers, Home Settings, and Hospital & Clinics. The Hospital & Clinics commanded largest market share of 42.56% in 2022, followed by Healthcare Payers.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom. The Americas commanded largest market share of 43.52% in 2022, followed by Europe, Middle East & Africa.
Market Statistics:

The report provides market sizing and forecasts across 7 major currencies - USD, EUR, JPY, GBP, AUD, CAD, and CHF; multiple currency support helps organization leaders to make well-informed decisions. In this report, 2018 to 2021 are considered as historical years, 2022 is base year, 2023 is estimated year, and years from 2024 to 2030 are considered as forecast period.

FPNV Positioning Matrix:

The FPNV Positioning Matrix is an indispensable tool for assessing the Specialty Drug Distribution Market. It comprehensively evaluates vendors, analyzing key metrics related to Business Strategy and Product Satisfaction. This enables users to make informed decisions tailored to their specific needs. Through advanced analysis, vendors are categorized into four distinct quadrants, each representing a different level of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V). Be assured that this insightful framework empowers decision-makers to navigate the market with confidence.

Market Share Analysis:

The Market Share Analysis offers invaluable insights into the vendor landscape Specialty Drug Distribution Market. By evaluating their impact on overall revenue, customer base, and other key metrics, we provide companies with a comprehensive understanding of their performance and the competitive environment they confront. This analysis also uncovers the level of competition in terms of market share acquisition, fragmentation, dominance, and industry consolidation during the study period.

Key Company Profiles:

The report delves into recent significant developments in the Specialty Drug Distribution Market, highlighting leading vendors and their innovative profiles. These include Aark Pharmaceuticals, Accredo Health Group, Inc., AmerisourceBergen Corporation, BioCare, Inc., Cardinal Health, Inc., Centene Corporation, China National Pharmaceutical Group Corporation, CVS Specialty, Inc., Elevance Health, Inc., Eversana, Feron Healthcare Pvt Ltd., Kroger Specialty Pharmacy, Lifeline Pharmaceuticals, LLC, McKesson Corporation, Medipal Holdings Corporation, Morris & Dickson Co., LLC, Optum, Inc., PHOENIX Pharmahandel GmbH & Co KG, Shanghai Pharmaceuticals Group Co., Ltd., Shields Health Solutions Holdings, LLC, Sun Pharmaceutical Industries Limited, Suzuken Co., Ltd., Teva Pharmaceutical Industries Ltd., and Walmart Inc..

The report offers valuable insights on the following aspects:
  1. Market Penetration: It provides comprehensive information about key players' market dynamics and offerings.
  2. Market Development: In-depth analysis of emerging markets and penetration across mature market segments, highlighting lucrative opportunities.
  3. Market Diversification: Detailed information about new product launches, untapped geographies, recent developments, and investments.
  4. Competitive Assessment & Intelligence: Exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of leading players.
  5. Product Development & Innovation: Intelligent insights on future technologies, R&D activities, and breakthrough product developments.
The report addresses key questions such as:
  1. What is the market size and forecast for the Specialty Drug Distribution Market?
  2. Which products, segments, applications, and areas hold the highest investment potential in the Specialty Drug Distribution Market?
  3. What is the competitive strategic window for identifying opportunities in the Specialty Drug Distribution Market?
  4. What are the latest technology trends and regulatory frameworks in the Specialty Drug Distribution Market?
  5. What is the market share of the leading vendors in the Specialty Drug Distribution Market?
  6. Which modes and strategic moves are suitable for entering the Specialty Drug Distribution Market?


Please Note: PDF & Excel + Online Access - 1 Year

Table of Contents

190 Pages
1. Preface
1.1. Objectives of the Study
1.2. Market Segmentation & Coverage
1.3. Years Considered for the Study
1.4. Currency & Pricing
1.5. Language
1.6. Limitations
1.7. Assumptions
1.8. Stakeholders
2. Research Methodology
2.1. Define: Research Objective
2.2. Determine: Research Design
2.3. Prepare: Research Instrument
2.4. Collect: Data Source
2.5. Analyze: Data Interpretation
2.6. Formulate: Data Verification
2.7. Publish: Research Report
2.8. Repeat: Report Update
3. Executive Summary
4. Market Overview
4.1. Introduction
4.2. Specialty Drug Distribution Market, by Region
5. Market Insights
5.1. Market Dynamics
5.1.1. Drivers
5.1.1.1. Increasing specialty drug development pipeline and trade
5.1.1.2. Emphasis on drug cost, supply, and storage optimization to offer patient-centric care
5.1.2. Restraints
5.1.2.1. Complexity in managing different distribution channels
5.1.3. Opportunities
5.1.3.1. New technology integration and advancements in specialty drug distribution
5.1.3.2. Rising expansion of specialty pharmacies worldwide
5.1.4. Challenges
5.1.4.1. Changing regulatory frameworks associated with specialty drug handling
5.2. Market Segmentation Analysis
5.3. Market Trend Analysis
5.3.1. Introduction of new digital ecosystems focusing on improving the distribution of specialty drugs in the Americas
5.3.2. Focus on specialty drug distribution network expansion in the Asia-Pacific region
5.3.3. Government initiatives for rare disease management and well-established pharma companies expand the market growth
5.4. Cumulative Impact of COVID-19
5.5. Cumulative Impact of Russia-Ukraine Conflict
5.6. Cumulative Impact of High Inflation
5.7. Porter’s Five Forces Analysis
5.7.1. Threat of New Entrants
5.7.2. Threat of Substitutes
5.7.3. Bargaining Power of Customers
5.7.4. Bargaining Power of Suppliers
5.7.5. Industry Rivalry
5.8. Value Chain & Critical Path Analysis
5.9. Regulatory Framework
5.10. Client Customization
5.10.1. Clinical Trials & Drug Development Pipeline
5.10.2. Speciality Drug Distribution Ecosystem
6. Specialty Drug Distribution Market, by Disease Indication
6.1. Introduction
6.2. AIDS
6.3. Hemophilia
6.4. Multiple Sclerosis
6.5. Oncology
6.6. Rheumatoid Arthritis
7. Specialty Drug Distribution Market, by Distributor Type
7.1. Introduction
7.2. Full line Wholesalers
7.3. Specialty Distributors
8. Specialty Drug Distribution Market, by Distribution Type
8.1. Introduction
8.2. Hospitals & Clinic Pharmacies
8.3. Independent Pharmacies
8.4. Large Chain Pharmacies
8.5. Mail-Order Pharmacies
8.6. Online Stores
8.7. Specialty Pharmacies
9. Specialty Drug Distribution Market, by End-User
9.1. Introduction
9.2. Ambulatory Surgical Centers
9.3. Healthcare Payers
9.4. Home Settings
9.5. Hospital & Clinics
10. Americas Specialty Drug Distribution Market
10.1. Introduction
10.2. Argentina
10.3. Brazil
10.4. Canada
10.5. Mexico
10.6. United States
11. Asia-Pacific Specialty Drug Distribution Market
11.1. Introduction
11.2. Australia
11.3. China
11.4. India
11.5. Indonesia
11.6. Japan
11.7. Malaysia
11.8. Philippines
11.9. Singapore
11.10. South Korea
11.11. Taiwan
11.12. Thailand
11.13. Vietnam
12. Europe, Middle East & Africa Specialty Drug Distribution Market
12.1. Introduction
12.2. Denmark
12.3. Egypt
12.4. Finland
12.5. France
12.6. Germany
12.7. Israel
12.8. Italy
12.9. Netherlands
12.10. Nigeria
12.11. Norway
12.12. Poland
12.13. Qatar
12.14. Russia
12.15. Saudi Arabia
12.16. South Africa
12.17. Spain
12.18. Sweden
12.19. Switzerland
12.20. Turkey
12.21. United Arab Emirates
12.22. United Kingdom
13. Competitive Landscape
13.1. FPNV Positioning Matrix
13.2. Market Share Analysis, By Key Player
13.3. Competitive Scenario Analysis, By Key Player
13.3.1. Merger & Acquisition
13.3.1.1. Elevance Health Announces Closing of BioPlus Acquisition
13.3.1.2. CVS Health to acquire Oak Street Health
13.3.1.3. Prime Therapeutics closes USD 1.35 billion Magellan Rx acquisition, uniting pharmacy and medical drug management expertise
13.3.1.4. Halozyme to Acquire Antares Pharma for around USD 960 million
13.3.2. Agreement, Collaboration, & Partnership
13.3.2.1. Everest Medicines Announces Strategic Partnership with Shanghai Pharma Subsidiary to Accelerate the Commercialization of XERAVA in Mainland China
13.3.2.2. Shields Health Solutions and MyMichigan Health Partner to Enhance Specialty Pharmacy Services for Patients and Families
13.3.2.3. Shields Health Solutions Expands Nationwide Partnerships to Enhance Specialty Pharmacy Services
13.3.2.4. Manulife and Shoppers Drug Mart collaborate to help manage serious medical conditions
13.3.3. New Product Launch & Enhancement
13.3.3.1. McKesson Canada Launches New Digital Ecosystem to Simplify and Enhance Specialty Patient Outcomes
13.3.4. Award, Recognition, & Expansion
13.3.4.1. Cardinal Health Continues to Expand at-Home Solutions Business
14. Competitive Portfolio
14.1. Key Company Profiles
14.1.1. Aark Pharmaceuticals
14.1.2. Accredo Health Group, Inc.
14.1.3. AmerisourceBergen Corporation
14.1.4. BioCare, Inc.
14.1.5. Cardinal Health, Inc.
14.1.6. Centene Corporation
14.1.7. China National Pharmaceutical Group Corporation
14.1.8. CVS Specialty, Inc.
14.1.9. Elevance Health, Inc.
14.1.10. Eversana
14.1.11. Feron Healthcare Pvt Ltd.
14.1.12. Kroger Specialty Pharmacy
14.1.13. Lifeline Pharmaceuticals, LLC
14.1.14. McKesson Corporation
14.1.15. Medipal Holdings Corporation
14.1.16. Morris & Dickson Co., LLC
14.1.17. Optum, Inc.
14.1.18. PHOENIX Pharmahandel GmbH & Co KG
14.1.19. Shanghai Pharmaceuticals Group Co., Ltd.
14.1.20. Shields Health Solutions Holdings, LLC
14.1.21. Sun Pharmaceutical Industries Limited
14.1.22. Suzuken Co., Ltd.
14.1.23. Teva Pharmaceutical Industries Ltd.
14.1.24. Walmart Inc.
14.2. Key Product Portfolio
15. Appendix
15.1. Discussion Guide
15.2. License & Pricing

Pricing

Currency Rates
How Do Licenses Work?

How Do Licenses Work?

The primary function of a report license is to define how many people within a company are authorized to use the purchased report. This is separate to how a report might be delivered. Unless specifically identified otherwise, the purchase option is Single User. Below is a helpful description of that license, along with a sampling of others most commonly offered.

  • This license allows only one user to have access to and to use/read the report. It is not one user at a time or one user group; it is an individual who will be reading and utilizing the report.

  • This license allows for the entire purchasing company to read and use the report. This is the license level that would allow for a report to be placed on an internal company shared drive for access by all employees of that direct company. This license does not extend to parent or sister company use.

  • This license is designed to allow an entire department within a company full access to a report. The departmental license is a great option for companies that have more than one location and the department is spread out all over the country/world

  • This license is for companies that have one location where they want the report to be accessible by all employees within that physical location.

  • This is the most flexible of the licensing options. Some publishers will allow you to get a license for a preset number of people (typically 5). These licenses are ideal for small work groups.

License options are at the discretion of each publisher. As such, not all licenses indicated above are available for every product. If you are uncertain of the best license for your needs or would like a license that is not proactively available, please contact us and we will be happy to assist.

Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
Chat Now
Contact Us